BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16155019)

  • 1. Molecular pathogenesis of diffuse large B-cell lymphoma.
    Lossos IS
    J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Skyrlas A; Agnantis NJ; Kamina S; Papoudou-Bai A; Kitsoulis P; Kanavaros P
    Anticancer Res; 2005; 25(1A):347-62. PubMed ID: 15816558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic biomarkers in diffuse large B-cell lymphoma.
    Lossos IS; Morgensztern D
    J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
    Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
    J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
    Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
    J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
    Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
    Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
    Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
    Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
    Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
    Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.
    Farinha P; Gascoyne RD
    J Clin Oncol; 2005 Sep; 23(26):6370-8. PubMed ID: 16155022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
    Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
    Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
    Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of gene expression profiling using cDNA arrays in lymphomas].
    Bertucci F; Salas S; Nasser V; Houlgatte R; Birnbaum D; Xerri L
    Bull Cancer; 2002; 89(7-8):661-5. PubMed ID: 12206978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffuse large cell lymphoma: new molecular approaches].
    Madrigal-Velázquez M; Avilés-Miranda A; Mayani H
    Rev Invest Clin; 2004; 56(4):483-94. PubMed ID: 15587295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
    Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
    Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
    Liggins AP; Cooper CD; Lawrie CH; Brown PJ; Collins GP; Hatton CS; Pulford K; Banham AH
    Br J Haematol; 2007 Aug; 138(4):479-86. PubMed ID: 17608765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.